QPA News	<< Back to overview
20 July 2021 Revised WHO Working Documents – European QP Association's IMP Group collects Comments In July 2021 the WHO issued the revised versions of their working documents "WHO good practices for research and development facilities of pharmaceutical products" "Good manufacturing practices for investigational products" for public consultation until 31 August 2021. For more detailed information on the new WHO documents please also see the news on the new WHO Draft on GMP for IMPs and the new WHO Draft on GxP for Development. We plan on providing the WHO with comprehensive comments for these revisions and therefore would like to invite you to also use the following commenting template  and return your comments by 15 August to IMPQP@qp-association.eu: Commenting Template for WHO working document "good practices for research and development facilities of pharmaceutical products" Commenting Template for WHO working document "good manufacturing practices for investigational products" The group will consolidate all comments received and submit one file to the WHO. The consolidated comments will also be posted in the IMP Group's members' area. We flagged this update already during last year’s QP Forum. To continue the dialog, it is already noted for the agenda of this year’s IMP Pre-conference in Berlin on 01 Dec 2021. << Back to overview